vEAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Feasibility Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorReuth Rehabilitation Hospital
About this trial
The goal of this clinical trial is to evaluate whether a culturally adapted, virtual, group-based emotional therapy called Emotional Awareness and Expression Therapy is feasible and whether it can help reduce chronic pain and improve emotional well-being among Israeli adults who suffer from chronic musculoskeletal pain and are treated with medical cannabis.
Participants will attend a weekly 1.5-hour virtual group therapy session for 8 weeks, except for the first session, which will be held in-person at the hospital's clinic. The participants will take part in group discussions and emotional processing exercises, complete questionnaires about pain levels, mood, sleep, and quality of life, and continue their usual medical treatment as prescribed by their doctors.
Eligibility criteria
Qualifiers
Diagnosed with any chronic musculoskeletal pain (≥ three months in duration) including back, neck, limb or pelvic pain, tension headache and fibromyalgia;
Treated with medical Cannabis;
Physical and mental ability to participate in group discussions;
Fluent in reading and speaking Hebrew.
Disqualifiers
Chronic pain conditions not classified as chronic primary pain. These include neuropathies such as carpal or tarsal tunnel syndrome, radiculopathy, and neuralgia;
Primary headache disorders such as cluster headaches;
Cancer-related pain;
Burn- or infection-related chronic pain;
Trial design
Treatments tested in this trial
- Group-based virtual Emotional Awareness & Expression Therapy - Hebrew (vEAET-H)
Treatment groups
42 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov